# Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer

> **NCT01747707** · PHASE2 · UNKNOWN · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 40 (estimated)

## Conditions studied

- Gastric Cancer
- Gastroesophageal Junction Cancer

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** Cisplatin
- **DRUG:** S-1

## Key facts

- **NCT ID:** NCT01747707
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2013-09
- **Final completion:** 2014-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2012-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01747707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01747707, "Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01747707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*